140 related articles for article (PubMed ID: 12134853)
1. Are selective COX 2 inhibitors superior to traditional NSAIDs? Pharmacia's response to editorial.
Geis GS
BMJ; 2002 Jul; 325(7356):161; author reply 161. PubMed ID: 12134853
[No Abstract] [Full Text] [Related]
2. Are selective COX 2 inhibitors superior to traditional NSAIDs? Both the CLASS and VIGOR trials support the COX 2 hypothesis.
Stover RR
BMJ; 2002 Jul; 325(7356):161; author reply 161. PubMed ID: 12134855
[No Abstract] [Full Text] [Related]
3. Cyclooxygenase (COX-2) selective inhibitors. Any better than NSAIDs?
Nguyen A; Chaiton A
Can Fam Physician; 2001 Jul; 47():1398-400. PubMed ID: 11494927
[No Abstract] [Full Text] [Related]
4. Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model.
Umar A; Boisseau M; Yusup A; Upur H; Bégaud B; Moore N
Fundam Clin Pharmacol; 2004 Oct; 18(5):559-63. PubMed ID: 15482377
[TBL] [Abstract][Full Text] [Related]
5. NSAIDs, Helicobacter pylori, and Pandora's Box.
Graham DY
N Engl J Med; 2002 Dec; 347(26):2162-4. PubMed ID: 12501230
[No Abstract] [Full Text] [Related]
6. Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.
Lanas A
N Engl J Med; 2003 Jun; 348(24):2464-6; author reply 2464-6. PubMed ID: 12802035
[No Abstract] [Full Text] [Related]
7. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level.
Varas-Lorenzo C; Maguire A; Castellsague J; Perez-Gutthann S
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):366-76. PubMed ID: 16897817
[TBL] [Abstract][Full Text] [Related]
8. New NSAIDs and gastroduodenal damage.
Folco GC
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():28-9. PubMed ID: 9032579
[TBL] [Abstract][Full Text] [Related]
9. [Capsule endoscopy study of gastrointestinal tolerance. Coxibes superior to NSAID plus antacid].
MMW Fortschr Med; 2004 Mar; 146(10):43. PubMed ID: 15347082
[No Abstract] [Full Text] [Related]
10. More pain for painkillers.
Sifferlin A
Time; 2013 Jun; 181(24):14. PubMed ID: 24044255
[No Abstract] [Full Text] [Related]
11. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
Goldstein JL; Eisen GM; Agrawal N; Stenson WF; Kent JD; Verburg KM
Aliment Pharmacol Ther; 2004 Sep; 20(5):527-38. PubMed ID: 15339324
[TBL] [Abstract][Full Text] [Related]
12. Digging for data from the COX-2 trials.
McCormack JP; Rangno R
CMAJ; 2002 Jun; 166(13):1649-50. PubMed ID: 12126315
[No Abstract] [Full Text] [Related]
13. The COX 2 selective inhibitors: what the newspapers have not told you.
Simon LS
Bull NYU Hosp Jt Dis; 2007; 65(3):229-41. PubMed ID: 17922675
[No Abstract] [Full Text] [Related]
14. Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib.
Patterson MK; Castellsague J; Walker AM
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):982-8. PubMed ID: 18711705
[TBL] [Abstract][Full Text] [Related]
15. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor.
Goldstein JL; Silverstein FE; Agrawal NM; Hubbard RC; Kaiser J; Maurath CJ; Verburg KM; Geis GS
Am J Gastroenterol; 2000 Jul; 95(7):1681-90. PubMed ID: 10925968
[TBL] [Abstract][Full Text] [Related]
16. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
[No Abstract] [Full Text] [Related]
17. [Analgesic in osteoporosis. Why so conservative with dosage?].
Pfeifer M
MMW Fortschr Med; 2002 Sep; 144(35-36):9. PubMed ID: 12380349
[No Abstract] [Full Text] [Related]
18. [A critical evaluation of side effect data on COX-2 inhibitors].
Pomp E
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):476-80. PubMed ID: 11961974
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib and the CLASS trial: data massaging by industry.
Prescrire Int; 2002 Dec; 11(62):190-1. PubMed ID: 12472103
[No Abstract] [Full Text] [Related]
20. Are rofecoxib and celecoxib safer NSAIDS?
Drug Ther Bull; 2000 Nov; 38(11):81-6. PubMed ID: 11138599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
